Clinical-stage biotech Neurizon Therapeutics has reported encouraging new rodent preclinical pharmacokinetic (PK) data for ...

The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and ...

Blood-Brain Barrier Penetration In the PK study NUZ-001 and its major active metabolite NUZ-001 Sulfone successfully crossed BBB, a key challenge for therapies targeting brain diseases.

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects ...

While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects ...

Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. But to influencers on TikTok, ...

DelveInsight's Traumatic Brain Injury pipeline report depicts a robust space with 20+ active players working to develop 22+ ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Brain swelling, or cerebral edema, is a medical emergency. Learn about the evidence-based treatments doctors use to reduce ...

HONG KONG SAR - Media OutReach Newswire - 6 December 2023 - A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer's disease (AD). The ...